Skip to main content

Advertisement

Log in

Long-term oncological outcomes of 3D versus 2D laparoscopic gastrectomy for gastric cancer: a randomized clinical trial

  • Original Article
  • Published:
Gastric Cancer Aims and scope Submit manuscript

Abstract

Background

Laparoscopy-assisted gastrectomy (LG) is rapidly gaining popularity owing to its minimal invasiveness. Previous studies have found that compared with two-dimensional (2D)-LG, three-dimensional (3D)-LG showed better short-term outcomes. However, the long-term oncological outcomes in patients with locally resectable gastric cancer (GC) remain controversial.

Methods

In this noninferiority, open-label, randomized clinical trial, a total of 438 eligible GC participants were randomly assigned in a 1:1 ratio to either 3D-LG or 2D-LG from January 2015 to April 2016. The primary endpoint was operating time, while the secondary endpoints included 5-year overall survival (OS), disease-free survival (DFS), and recurrence pattern.

Results

Data from 401 participants were included in the per-protocol analysis, with 204 patients in the 3D group and 197 patients in the 2D group. The 5-year OS and DFS rates were comparable between the 3D and 2D groups (5-year OS: 70.6% vs. 71.1%, Log-rank P = 0.743; 5-year DFS: 68.1% vs. 69.0%, log-rank P = 0.712). No significant differences were observed between the 3D and 2D groups in the 5-year recurrence rate (28.9% vs. 28.9%, P = 0.958) or recurrence time (mean time, 22.6 vs. 20.5 months, P = 0.412). Further stratified analysis based on the type of gastrectomy, postoperative pathological staging, and preoperative BMI showed that the 5-year OS, DFS, and recurrence rates of the 3D group in each subgroup were similar to those of the 2D group (all P > 0.05).

Conclusions

For patients with locally resectable GC, 3D-LG performed by experienced surgeons in high-volume professional institutions can achieve long-term oncological outcomes comparable to those of 2D-LG.

Registration number

NCT02327481 (http://clinicaltrials.gov).

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

    Article  PubMed  Google Scholar 

  2. Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet (London). 2020;396(10251):635–48.

    Article  CAS  Google Scholar 

  3. Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994;4(2):146–8.

    CAS  PubMed  Google Scholar 

  4. Iino I, Sakaguchi T, Kikuchi H, Miyazaki S, Fujita T, Hiramatsu Y, Ohta M, Kamiya K, Ushio T, Takehara Y, et al. Usefulness of three-dimensional angiographic analysis of perigastric vessels before laparoscopic gastrectomy. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2013;16(3):355–61.

    Google Scholar 

  5. Smith R, Schwab K, Day A, Rockall T, Ballard K, Bailey M, Jourdan I. Effect of passive polarizing three-dimensional displays on surgical performance for experienced laparoscopic surgeons. Br J Surg. 2014;101(11):1453–9.

    Article  CAS  PubMed  Google Scholar 

  6. Sørensen SMD, Savran MM, Konge L, Bjerrum F. Three-dimensional versus two-dimensional vision in laparoscopy: a systematic review. Surg Endosc. 2016;30(1):11–23.

    Article  PubMed  Google Scholar 

  7. Park CH, Park JC, Chung H, Shin SK, Lee SK, Cheong J-H, Hyung WJ, Lee YC, Noh SH, Kim CB. Impact of the surveillance interval on the survival of patients who undergo curative surgery for gastric cancer. Ann Surg Oncol. 2016;23(2):539–45.

    Article  PubMed  Google Scholar 

  8. Au KP, Chan MY, Chu KW, Kwan CLY, Ma KW, She WH, Tsang SHY, Dai WC, Cheung TT, Chan ACY. Impact of three-dimensional (3D) visualization on laparoscopic hepatectomy for hepatocellular carcinoma. Ann Surg Oncol. 2022;29(11):6731–44.

    Article  PubMed  Google Scholar 

  9. Agrusa A, di Buono G, Chianetta D, Sorce V, Citarrella R, Galia M, Vernuccio L, Romano G, Gulotta G. Three-dimensional (3D) versus two-dimensional (2D) laparoscopic adrenalectomy: a case–control study. Int J Surg (London). 2016;28(Suppl 1):S114–7.

    Article  Google Scholar 

  10. Ashraf A, Collins D, Whelan M, O’Sullivan R, Balfe P. Three-dimensional (3D) simulation versus two-dimensional (2D) enhances surgical skills acquisition in standardised laparoscopic tasks: a before and after study. Int J Surg (Lond). 2015;14:12–6.

    Article  CAS  Google Scholar 

  11. Gabrielli ME, Saun TJ, Jung JJ, Grantcharov TP. Assessment of 3-dimensional vs. 2-dimensional imaging and technical performance using a multiport intraoperative data capture and analytic system for patients undergoing laparoscopic roux-en-y gastric bypass surgery. JAMA Netw Open. 2020;3(1):e1920084.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Katai H, Mizusawa J, Katayama H, Takagi M, Yoshikawa T, Fukagawa T, Terashima M, Misawa K, Teshima S, Koeda K, et al. Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2017;20(4):699–708.

    Google Scholar 

  13. Zheng C-H, Lu J, Zheng H-L, Li P, Xie J-W, Wang J-B, Lin J-X, Chen Q-Y, Cao L-L, Lin M, et al. Comparison of 3D laparoscopic gastrectomy with a 2D procedure for gastric cancer: a phase 3 randomized controlled trial. Surgery. 2018;163(2):300–4.

    Article  PubMed  Google Scholar 

  14. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077–9.

    Article  PubMed  Google Scholar 

  15. Gong J-Q, Cao Y-K, Wang Y-H, Zhang G-H, Wang P-H, Luo G-D. Learning curve for hand-assisted laparoscopic D2 radical gastrectomy. World J Gastroenterol. 2015;21(5):1606–13.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Morris JS. Disease-free survival is a promising surrogate for overall survival in colorectal cancer studies. J Natl Cancer Inst. 2022;114(1):5–6.

    Article  PubMed  Google Scholar 

  17. Hung JJ, Hsu WH, Hsieh CC, Huang BS, Huang MH, Liu JS, Wu YC. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax. 2009;64(3):192–6.

    Article  PubMed  Google Scholar 

  18. Ajao MO, Larsen CR, Manoucheri E, Goggins ER, Rask MT, Cox MKB, Mushinski A, Gu X, Cohen SL, Rudnicki M, et al. Two-dimensional (2D) versus three-dimensional (3D) laparoscopy for vaginal cuff closure by surgeons-in-training: a randomized controlled trial. Surg Endosc. 2020;34(3):1237–43.

    Article  PubMed  Google Scholar 

  19. Mashiach R, Mezhybovsky V, Nevler A, Gutman M, Ziv A, Khaikin M. Three-dimensional imaging improves surgical skill performance in a laparoscopic test model for both experienced and novice laparoscopic surgeons. Surg Endosc. 2014;28(12):3489–93.

    Article  PubMed  Google Scholar 

  20. Chen Q-Y, Xie J-W, Zhong Q, Wang J-B, Lin J-X, Lu J, Cao L-L, Lin M, Tu R-H, Huang Z-N, et al. Safety and efficacy of indocyanine green tracer-guided lymph node dissection during laparoscopic radical gastrectomy in patients with gastric cancer: a randomized clinical trial. JAMA Surg. 2020;155(4):300–11.

    Article  PubMed  Google Scholar 

  21. Wang J, Wang Q, Dong J, Yang K, Ji S, Fan Y, Wang C, Ma Q, Wei Q, Ji G. Total laparoscopic uncut roux-en-Y for radical distal gastrectomy: an interim analysis of a randomized, controlled. Clin Trial Ann Surg Oncol. 2021;28(1):90–6.

    Article  Google Scholar 

  22. Hu Y, Huang C, Sun Y, Su X, Cao H, Hu J, Xue Y, Suo J, Tao K, He X, et al. Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial. J Clin Oncol Off J Am Soc Clin Oncol. 2016;34(12):1350–7.

    Article  Google Scholar 

  23. Herron DM, Lantis JC, Maykel J, Basu C, Schwaitzberg SD. The 3-D monitor and head-mounted display. A quantitative evaluation of advanced laparoscopic viewing technologies. Surg Endosc. 1999;13(8):751–5.

    Article  CAS  PubMed  Google Scholar 

  24. Wang W-J, Li H-T, Yu J-P, Su L, Guo C-A, Chen P, Yan L, Li K, Ma Y-W, Wang L, et al. Severity and incidence of complications assessed by the Clavien–Dindo classification following robotic and laparoscopic gastrectomy for advanced gastric cancer: a retrospective and propensity score-matched study. Surg Endosc. 2019;33(10):3341–54.

    Article  PubMed  Google Scholar 

  25. Tokunaga M, Sugisawa N, Kondo J, Tanizawa Y, Bando E, Kawamura T, Terashima M. Early phase II study of robot-assisted distal gastrectomy with nodal dissection for clinical stage IA gastric cancer. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2014;17(3):542–7.

    CAS  Google Scholar 

  26. Yang K, Cho M, Roh CK, Seo WJ, Choi S, Son T, Kim H-I, Hyung WJ. Robotic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. Surg Endosc. 2019;33(7):2357–63.

    Article  PubMed  Google Scholar 

  27. Jiang Y, Zhao Y, Qian F, Shi Y, Hao Y, Chen J, Li P, Yu P. The long-term clinical outcomes of robotic gastrectomy for gastric cancer: a large-scale single institutional retrospective study. Am J Transl Res. 2018;10(10):3233–42.

    PubMed  PubMed Central  Google Scholar 

  28. Hyung WJ, Yang HK, Park YK, Lee HJ, An JY, Kim W, Kim HI, Kim HH, Ryu SW, Hur H, Kim MC, Kong SH, Cho GS, Kim JJ, Park DJ, Ryu KW, Kim YW, Kim JW, Lee JH, Han SU. Korean laparoendoscopic gastrointestinal surgery study group. Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: The KLASS-02-RCT Randomized Clinical Trial. J Clin Oncol. 2020;38(28):3304–13.

    Article  PubMed  Google Scholar 

  29. Kim HH, Han SU, Kim MC, Kim W, Lee HJ, Ryu SW, Cho GS, Kim CY, Yang HK, Park DJ, Song KY, Lee SI, Ryu SY, Lee JH, Hyung WJ. Korean laparoendoscopic gastrointestinal surgery study (KLASS) group effect of laparoscopic distal gastrectomy vs. Open distal gastrectomy on long-term survival among patients with stage I gastric cancer: the KLASS-01 randomized clinical trial. JAMA Oncol. 2019;5(4):506–13.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Lee K, Youn SI, Won Y, Min SH, Park YS, Ahn SH, Park DJ, Kim HH. Prospective randomized controlled study for comparison of 2-dimensional versus 3-dimensional laparoscopic distal gastrectomy for gastric adenocarcinoma. Surg Endosc. 2021;35(2):934–40.

    Article  PubMed  Google Scholar 

  31. Greenhill C. Gastric cancer. Metformin improves survival and recurrence rate in patients with diabetes and gastric cancer. Nat Rev Gastroenterol Hepatol. 2015;12(3):124.

    Article  PubMed  Google Scholar 

  32. Chang JS, Kim KH, Yoon HI, Hyung WJ, Rha SY, Kim HS, Lee YC, Lim JS, Noh SH, Koom WS. Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer. Br J Surg. 2017;104(7):877–84.

    Article  CAS  PubMed  Google Scholar 

  33. Lee JH, Chang KK, Yoon C, Tang LH, Strong VE, Yoon SS. Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma. Ann Surg. 2018;267(1):105–13.

    Article  PubMed  Google Scholar 

  34. Lee D, Son S-Y, Kim Y-B, Han S-U, Hur H. Neural invasion is a significant contributor to peritoneal recurrence in signet ring cell gastric carcinoma. Ann Surg Oncol. 2018;25(5):1167–75.

    Article  PubMed  Google Scholar 

  35. Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, Kodaira S, Okajima K, Nakazato H. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2003;6(3):142–5.

    Google Scholar 

  36. Kim SH, Song BI, Kim HW, Won KS, Son YG, Ryu SW. Prognostic value of restaging F-18 fluorodeoxyglucose positron emission tomography/computed tomography to predict 3-year post-recurrence survival in patients with recurrent gastric cancer after curative resection. Korean J Radiol. 2020;21(7):829–37.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Cardoso R, Coburn NG, Seevaratnam R, Mahar A, Helyer L, Law C, Singh S. A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2012;15(Suppl 1):S164–7.

    Google Scholar 

  38. Özgüner O, Shkurti T, Huang S, Hao R, Jackson RC, Newman WS, Çavuşoğlu MC. Camera-robot calibration for the da Vinci® robotic surgery system. IEEE Trans Autom Sci Eng. 2020;17(4):2154–61.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Hashizume M, Sugimachi K. Robot-assisted gastric surgery. Surg Clin North Am. 2003;83(6):1429–44.

    Article  PubMed  Google Scholar 

  40. Tian Y, Guo H, Hu Y, Yang P, Liu Y, Zhang Z, Ding P, Zheng T, Fan L, Zhang Z, et al. Safety and efficacy of robotic-assisted versus laparoscopic distal gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer. Surg Endosc. 2023;1:1.

    Google Scholar 

  41. Shim JH, Kim JG, Jeon HM, Park CH, Song KY. The robotic third arm as a competent analog of an assisting surgeon in radical gastrectomy: impact on short-term clinical outcomes. J Laparoendosc Adv Surg Tech A. 2013;23(5):447–51.

    Article  PubMed  Google Scholar 

  42. Han D-S, Suh Y-S, Ahn HS, Kong S-H, Lee H-J, Kim W-H, Yang H-K. Comparison of surgical outcomes of robot-assisted and laparoscopy-assisted pylorus-preserving gastrectomy for gastric cancer: a propensity score matching analysis. Ann Surg Oncol. 2015;22(7):2323–8.

    Article  PubMed  Google Scholar 

  43. Yoon HM, Kim Y-W, Lee JH, Ryu KW, Eom BW, Park JY, Choi IJ, Kim CG, Lee JY, Cho SJ, et al. Robot-assisted total gastrectomy is comparable with laparoscopically assisted total gastrectomy for early gastric cancer. Surg Endosc. 2012;26(5):1377–81.

    Article  PubMed  Google Scholar 

  44. Lu J, Wu D, Huang JB, Lin J, Xu BB, Xue Z, Zheng HL, Lin GS, Shen LL, Li P, Wang JB, Lin JX, Chen QY, Cao LL, Xie JW, Zheng CH, Huang CM. Comparison of robotic versus laparoscopic versus open distal gastrectomy for locally advanced gastric cancer: a prospective trial-based economic evaluation. Surg Endosc. 2023;37(10):7472–85.

    Article  PubMed  Google Scholar 

  45. Lu J, Zheng HL, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Tu RH, Huang ZN, Huang CM, Zheng CH. A propensity score-matched comparison of robotic versus laparoscopic gastrectomy for gastric cancer: oncological, cost, and surgical stress analysis. J Gastrointest Surg. 2018;22(7):1152–62.

    Article  PubMed  Google Scholar 

  46. Tian Y, Lin Y, Sun C, Lowe S, Bentley R, Yang P, Guo H, Ding P, Zhang Z, Wang D, et al. Comparison of short-term efficacy and safety between total robotic and total 3D laparoscopic distal radical gastrectomy for gastric cancer in Enhanced Recovery After Surgery (ERAS) protocol: a propensity score matching study. J Robot Surg. 2023;17(3):1151–8.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Fanfani F, Rossitto C, Restaino S, Ercoli A, Chiantera V, Monterossi G, Barbati G, Scambia G. How technology can impact surgeon performance: a randomized trial comparing 3-dimensional versus 2-dimensional laparoscopy in gynecology oncology. J Minim Invasive Gynecol. 2016;23(5):810–7.

    Article  PubMed  Google Scholar 

  48. Ko JK, Li RH, Cheung VY. Two-dimensional versus three-dimensional laparoscopy: evaluation of physicians’ performance and preference using a pelvic trainer. J Minim Invasive Gynecol. 2015;22(3):421–7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank those who have devoted a lot to this study, including nurses, pathologists, further-study surgeons, statisticians, reviewers and editors. Thanks for Dr. Zhi-Hong Huang, Public Technology Service Center, Fujian Medical University. We would like to thank Editage (www.editage.cn) for English language editing. They were not financially compensated for their contributions.

Funding

This study was supported by Province Medical “Creating high-level hospitals, high-level medical centers and key specialty projects” [MWYZ (2021) No. 76], Talent Initiation Fund Project of Fujian Medical University Union Hospital (2022XH041), Yunnan Provincial Science and Technology Department (202105AF150040).

Author information

Authors and Affiliations

Authors

Contributions

Concept and design: ZQ, CJY, SGZX, HCM, and ZCH. Acquisition, analysis, or interpretation of data: CJY, SGZX, LGT, and LZY. Drafting of the manuscript: ZQ, CJY, SGZX, LJ, HCM, and ZCH. Statistical analysis: ZQ, CJY, SGZX, and LJ. Administrative, technical, or material support: LZY, LGT, WD, JYM, WJB, LJX, CQY, LJL, XJW, and LP. Supervision: ZQ, CJY, and SGZX.

Corresponding author

Correspondence to Chao-Hui Zheng.

Ethics declarations

Ethics approval and consent to participate

This study was conducted with the approval of the Biomedical ethical review committee of Fujian Medical University of China (IRB:2014019).

Consent for publication

This manuscript has not been published or presented elsewhere in part or in entirety and is not under consideration by another journal.

Conflict of interest

All authors have no conflict of interest and no potential benefits. The institutional review boards of all the participating institutions approved the study. The authors have no other disclosures to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file 1

. Supplemental Digital Content 1. FUGES-001 Study Protocol ver.1.1. (DOCX 15272 kb)

Supplementary file 2

. Supplemental Digital Content 2. eTables and eFigures. eTable 1. Eligibility Criteria for Enrolling Patients. eTable 2. Univariable and Multivariable Cox Regression Analyses of Risk Factors for PRS. eTable 3. Frequencies of Causes of First Recurrence Within 5 Years After Surgery between 3D and 2D Groups in patients with total gastrectomy. eTable 4. Frequencies of Causes of First Recurrence Within 5 Years After Surgery between 3D and 2D Groups in patients with distal gastrectomy. eTable 5. Frequencies of Causes of First Recurrence Within 5 Years After Surgery. between 3D and 2D Groups in patients of pI staging. eTable 6. Frequencies of Causes of First Recurrence Within 5 Years After Surgery between 3D and 2D Groups in patients of pII staging. eTable 7. Frequencies of Causes of First Recurrence Within 5 Years After Surgery between 3D and 2D Groups in patients of pIII staging. eTable 8. Frequencies of Causes of First Recurrence Within 5 Years After Surgery between 3D and 2D Groups in patients of BMI ≤ 25. eTable 9. Frequencies of Causes of First Recurrence Within 5 Years After Surgery between 3D and 2D Groups in patients of BMI > 25. eFig. 1: Cumulative Incidence of Any Recurrence for 3D versus 2D Group within 5 Years after Surgery. eFig. 2: Recurrent site columnar distribution map. eFig. 3: Postoperative recurrence time nuclear density map. eFig. 4: Post-recurrence survival for 3D-Laparoscopic Gastrectomy versus 2D-Laparoscopic Gastrectomy at 5 Years After Surgery. eFig. 5. Kaplan–Meier Curves Comparing Overall Survival (A) and Disease-free Survival (B) Between the 3D Group and 2D Group in patients with total gastrectomy. eFig. 6. Kaplan–Meier Curves Comparing Overall Survival (A) and Disease-free Survival (B) Between the 3D Group and 2D Group in patients with distal gastrectomy. eFig. 7. Kaplan–Meier Curves Comparing Overall Survival (A) and Disease-free Survival (B) Between the 3D Group and 2D Group in patients of pI staging. eFig. 8. Kaplan–Meier Curves Comparing Overall Survival (A) and Disease-free Survival (B) Between the 3D Group and 2D Group in patients of pII staging. eFig. 9. Kaplan–Meier Curves Comparing Overall Survival (A) and Disease-free Survival (B) Between the 3D Group and 2D Group in patients of pIII staging. eFig. 10. Kaplan–Meier Curves Comparing Overall Survival (A) and Disease-free Survival (B) Between the 3D Group and 2D Group in patients of BMI ≤ 25. eFig. 11. Kaplan–Meier Curves Comparing Overall Survival (A) and Disease-free Survival (B) Between the 3D Group and 2D Group in patients of BMI > 25. (DOCX 1271 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhong, Q., Chen, JY., Shang-Guan, ZX. et al. Long-term oncological outcomes of 3D versus 2D laparoscopic gastrectomy for gastric cancer: a randomized clinical trial. Gastric Cancer 27, 598–610 (2024). https://doi.org/10.1007/s10120-024-01470-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10120-024-01470-0

Keywords

Navigation